CAI Unveils Bold New Brand Identity at ISPE Annual Meeting & Expo
Orlando, FL – [October 14, 2024] – CAI, a trailblazer in operational readiness and excellence, is thrilled to announce a comprehensive rebranding initiative, set to launch...
Read MoreCAI Appoints Sheena Dempsey as Chief Executive Officer
Indianapolis (October 2, 2024)—CAI, a global professional services firm and trailblazer in operational readiness and excellence, today announced Sheena Dempsey as Chief Executive Officer (CEO)....
Read MoreHow Digital Twins are Optimizing Biotechnology Production and Changing the Workforce for the Future
The workforce is transforming rapidly, driven by technological advancements like Digital Twins. These virtual models replicate real-world systems in a digital space, and their integration...
Read MoreThe Handover Stage of Technology Transfer: Ensuring a Seamless Transition for Commercial Production
Transitioning from technology transfer (TT) to routine commercial production poses significant challenges for biopharmaceutical companies. Ensuring a seamless handover from the TT Team to the...
Read MoreLESSONS LEARNED FROM IMPLEMENTING THE FDA’s CSA GUIDANCE: PART 3 –SUMMARIZING
This is the last installment of a three-article series that presents several lessons learned by our validation team while completing a pair of validation projects...
Read MorePlanning for a Talented Workforce: Building a Staffing Plan for New or Expanding GMP Facilities
Let’s contrast two very real scenarios: You are responsible for bringing a new GMP facility or line to full-scale production. Your board or shareholders expect...
Read MoreICH Q9 Revision 1: Updates to Enhance Quality Risk Management in the Pharmaceutical Industry and a Pathway to a Robust Contamination Control Strategy
Originally issued in 2005, ICH Q9 laid down principles and examples of tools for QRM that can be applied throughout the product lifecycle. It was...
Read MoreAchieving Operational Goals with CAI
In today's rapidly changing market, companies must be agile and adaptable to meet fluctuating demands. Achieving operational goals amidst these changes requires flexibility in production...
Read MoreLeveraging CAI Human Performance Services for the “People in Plant” Program: Driving Excellence in Pharmaceutical Manufacturing
The "People in Plant" (PiP) program is pivotal in recognizing and enhancing the contributions of employees in a pharmaceutical manufacturing facility. Implementing such a comprehensive...
Read More